estrone has been researched along with Endometrial Hyperplasia in 28 studies
Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.
Endometrial Hyperplasia: Benign proliferation of the ENDOMETRIUM in the UTERUS. Endometrial hyperplasia is classified by its cytology and glandular tissue. There are simple, complex (adenomatous without atypia), and atypical hyperplasia representing also the ascending risk of becoming malignant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A regime of cyproterone acetate (CPA) (300 mg/day by the oral route for 30 days) has been used in 10 post-menopausal women with endometrial hyperplasia (8 atypical and 2 adenomatous)." | 7.67 | Treatment of endometrial hyperplasia with cyproterone acetate histological and hormonal aspects. ( Bulletti, C; Ciotti, P; Flamigni, C; Franceschetti, F; Jasonni, VM; Marabini, A; Naldi, S; Vignudelli, A, 1986) |
| "Plasma androstenedione (A) levels and plasma oestrone (E1) levels were measured by radioimmunoassay in a total of 135 healthy women (the control group), around the menopause." | 7.66 | Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium. ( Battaglia, F; Mango, D; Montemurro, A; Scirpa, P; Scirpa, S, 1982) |
| " Ten patients with histologically proven endometrial hyperplasia were treated with Danazol at a dosage of 600 mg/day for 30 days." | 5.27 | Preliminary report on postmenopausal endometrial hyperplasia treatment with Danazol: histological and endocrinological aspects. ( Bulletti, C; Ciotti, P; Flamigni, C; Jasonni, VM; La Marca, L; Naldi, S; Vignudelli, A, 1986) |
| "A regime of cyproterone acetate (CPA) (300 mg/day by the oral route for 30 days) has been used in 10 post-menopausal women with endometrial hyperplasia (8 atypical and 2 adenomatous)." | 3.67 | Treatment of endometrial hyperplasia with cyproterone acetate histological and hormonal aspects. ( Bulletti, C; Ciotti, P; Flamigni, C; Franceschetti, F; Jasonni, VM; Marabini, A; Naldi, S; Vignudelli, A, 1986) |
| "Plasma androstenedione (A) levels and plasma oestrone (E1) levels were measured by radioimmunoassay in a total of 135 healthy women (the control group), around the menopause." | 3.66 | Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium. ( Battaglia, F; Mango, D; Montemurro, A; Scirpa, P; Scirpa, S, 1982) |
| " Ten patients with histologically proven endometrial hyperplasia were treated with Danazol at a dosage of 600 mg/day for 30 days." | 1.27 | Preliminary report on postmenopausal endometrial hyperplasia treatment with Danazol: histological and endocrinological aspects. ( Bulletti, C; Ciotti, P; Flamigni, C; Jasonni, VM; La Marca, L; Naldi, S; Vignudelli, A, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (78.57) | 18.7374 |
| 1990's | 2 (7.14) | 18.2507 |
| 2000's | 3 (10.71) | 29.6817 |
| 2010's | 1 (3.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lobo, RA | 1 |
| Liu, J | 1 |
| Stanczyk, FZ | 1 |
| Constantine, GD | 1 |
| Pickar, JH | 2 |
| Shadiack, AM | 1 |
| Bernick, B | 1 |
| Mirkin, S | 1 |
| Bochkareva, NV | 1 |
| Kolomiets, LA | 1 |
| Kondakova, IV | 1 |
| Stukanov, SL | 1 |
| Tropina, TV | 1 |
| Muntian, AB | 1 |
| POLISHUK, WZ | 1 |
| PLUNKETT, ER | 1 |
| KASE, N | 1 |
| Deng, L | 1 |
| Broaddus, RR | 1 |
| McCampbell, A | 1 |
| Shipley, GL | 1 |
| Loose, DS | 1 |
| Stancel, GM | 1 |
| Davies, PJ | 1 |
| Goldzieher, JW | 1 |
| Fariss, B | 1 |
| Prost, O | 1 |
| Adessi, GL | 1 |
| Pelusi, G | 1 |
| Moretti, B | 1 |
| Martinelli, G | 1 |
| Camerini, T | 1 |
| Busacchi, P | 1 |
| Cavallina, R | 1 |
| Kasai, T | 1 |
| Takeda, B | 1 |
| Takamizawa, H | 1 |
| Scirpa, P | 1 |
| Mango, D | 1 |
| Battaglia, F | 1 |
| Scirpa, S | 1 |
| Montemurro, A | 1 |
| Forney, JP | 1 |
| Milewich, L | 1 |
| Chen, GT | 1 |
| Garlock, JL | 1 |
| Schwarz, BE | 1 |
| Edman, CD | 2 |
| MacDonald, PC | 2 |
| James, VH | 2 |
| Reed, MJ | 2 |
| Folkerd, EJ | 1 |
| Klemi, PJ | 1 |
| Grönroos, M | 1 |
| Rauramo, L | 1 |
| Punnonen, R | 1 |
| Niwa, K | 1 |
| Murase, T | 1 |
| Furui, T | 1 |
| Morishita, S | 1 |
| Mori, H | 2 |
| Tanaka, T | 1 |
| Tamaya, T | 1 |
| Rebar, RW | 1 |
| Trabal, J | 1 |
| Mortola, J | 1 |
| Whitehead, MI | 2 |
| Badawy, SZ | 1 |
| Elliott, LJ | 1 |
| Elbadawi, A | 1 |
| Marshall, LD | 1 |
| Grodin, JM | 1 |
| Vellios, F | 1 |
| Siiteri, PK | 1 |
| Brush, MG | 1 |
| Milton, PJ | 1 |
| Swain, M | 1 |
| Moore, J | 1 |
| Harris, ST | 1 |
| Genant, HK | 1 |
| Baylink, DJ | 1 |
| Gallagher, JC | 1 |
| Karp, SK | 1 |
| McConnell, MA | 1 |
| Green, EM | 1 |
| Stoll, RW | 1 |
| Jasonni, VM | 3 |
| Franceschetti, F | 1 |
| Ciotti, P | 3 |
| Bulletti, C | 3 |
| Vignudelli, A | 2 |
| Marabini, A | 1 |
| Naldi, S | 2 |
| Flamigni, C | 3 |
| Tabanelli, S | 1 |
| Cappuccini, F | 1 |
| Borini, A | 1 |
| La Marca, L | 1 |
| Beranek, PA | 1 |
| Ghilchik, MW | 1 |
| Rader, MD | 1 |
| Flickinger, GL | 1 |
| DeVilla, GO | 1 |
| Mikuta, JJ | 1 |
| Mikhail, G | 1 |
| Markovski, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Aromatase Inhibitors: Skeletal Effects and the Role of CYP19 Gene Polymorphisms[NCT00603967] | 151 participants (Actual) | Interventional | 2006-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for estrone and Endometrial Hyperplasia
| Article | Year |
|---|---|
Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules).
Topics: Adult; Aged; Biological Availability; Endometrial Hyperplasia; Estradiol; Estrone; Female; Hot Flash | 2019 |
Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer.
Topics: Adenocarcinoma; Biomarkers, Tumor; Case-Control Studies; Endometrial Hyperplasia; Endometrial Neopla | 2005 |
Low-dose esterified estrogens (0.3 mg/day): long-term and short-term effects on menopausal symptoms and quality of life in postmenopausal women.
Topics: Double-Blind Method; Endometrial Hyperplasia; Equilin; Estrogen Replacement Therapy; Estrone; Female | 2000 |
The effects of estrone (Ogen) on spinal bone density of postmenopausal women.
Topics: Bone Density; Dose-Response Relationship, Drug; Double-Blind Method; Endometrial Hyperplasia; Estron | 1991 |
24 other studies available for estrone and Endometrial Hyperplasia
| Article | Year |
|---|---|
[Sex hormones in the systemic and local circulation in endometrial hyperplasia and neoplasia: correlation with the activity of estrogen-metabolizing enzymes].
Topics: Androstenedione; Aromatase; Endometrial Hyperplasia; Endometrial Neoplasms; Estradiol; Estrone; Fema | 2008 |
A case of pyometra due to prolonged oestrone administration.
Topics: Endometrial Hyperplasia; Estrone; Female; Humans; Pyometra; Suppuration; Uterus | 1963 |
DRUGS FOR FUNCTIONAL UTERINE BLEEDING.
Topics: Contraceptive Agents; Contraceptives, Oral; Diethylstilbestrol; Dosage Forms; Drug Therapy; Dydroges | 1964 |
STEROID SYNTHESIS IN ABNORMAL OVARIES. II. GRANULOSA CELL TUMOR.
Topics: Androgens; Chromatography; Corpus Luteum Hormones; Dehydroepiandrosterone; Endometrial Hyperplasia; | 1964 |
The polycystic ovary. VII. Intractable uterine bleeding and endometrial hyperplasia possibly related to an extraovarian source of oestrogen.
Topics: 17-Ketosteroids; Adrenal Glands; Adult; Androgens; Chromatography; Cysts; Endometrial Hyperplasia; E | 1967 |
Estrone and dehydroepiandrosterone sulfatase activities in normal and pathological human endometrium biopsies.
Topics: Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Endometrial Hyperplasia; Endometrium; Estron | 1983 |
Behavior of some steroids in endometrial adenomatous and atypical hyperplasia.
Topics: Adult; Androgens; Androstenedione; Dehydroepiandrosterone; Endometrial Hyperplasia; Estradiol; Estro | 1983 |
[Studies on the early diagnosis of endometrial carcinoma. Analysis of risk factors and cytological approach].
Topics: Adult; Aged; Cytodiagnosis; Endometrial Hyperplasia; Estrone; Female; Humans; Menopause; Middle Aged | 1984 |
Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aging; Androstenedione; Endometrial Hyperplasia; Estrone; F | 1982 |
Aromatization of androstenedione to estrone by human adipose tissue in vitro. Correlation with adipose tissue mass, age, and endometrial neoplasia.
Topics: Adipose Tissue; Adult; Aged; Aging; Androstenedione; Aromatase; Endometrial Hyperplasia; Estrone; Fe | 1981 |
Studies of oestrogen metabolism in postmenopausal women with cancer.
Topics: Adipose Tissue; Aged; Androstenedione; Body Weight; Breast Neoplasms; Endometrial Hyperplasia; Estra | 1981 |
Ultrastructural features of endometrial atypical adenomatous hyperplasia and adenocarcinomas and the plasma level of estrogens.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Endometrial Hyperplasia; Estradiol; Estriol; Estroge | 1980 |
Enhancing effects of estrogens on endometrial carcinogenesis initiated by N-methyl-N-nitrosourea in ICR mice.
Topics: Adenocarcinoma; Animals; Endometrial Hyperplasia; Endometrial Neoplasms; Estradiol; Estriol; Estrone | 1993 |
The effects of oestrogens and progestogens on the postmenopausal endometrium.
Topics: Endometrial Hyperplasia; Endometrium; Estrogens; Estrone; Female; Humans; Menopause; Menstruation; M | 1978 |
Plasma levels of oestrone and oestradiol-17beta in postmenopausal women.
Topics: Adult; Age Factors; Aged; Body Weight; Endometrial Hyperplasia; Estradiol; Estrogens; Estrone; Femal | 1979 |
Origin of estrogen in a postmenopausal woman with a nonendocrine tumor of the ovary and endometrial hyperplasia.
Topics: Androgens; Androstenedione; Castration; Cystadenoma; Endometrial Hyperplasia; Estrogens; Estrone; Fe | 1976 |
Proceedings: Endocrine factors in the aetiology of cystic hyperplasia of endometrium.
Topics: Adult; Cysts; Endometrial Hyperplasia; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating H | 1975 |
Treatment of endometrial hyperplasia with cyproterone acetate histological and hormonal aspects.
Topics: Androgen Antagonists; Androstenedione; Cyproterone; Cyproterone Acetate; Endometrial Hyperplasia; Es | 1986 |
Prevention of endometrial abnormalities.
Topics: Endometrial Hyperplasia; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female | 1986 |
Increased extraction of estrogens in human endometrial hyperplasia and carcinoma.
Topics: Adenocarcinoma; Endometrial Hyperplasia; Endometrium; Estradiol; Estrone; Female; Humans; Perfusion; | 1988 |
Preliminary report on postmenopausal endometrial hyperplasia treatment with Danazol: histological and endocrinological aspects.
Topics: Danazol; Endometrial Hyperplasia; Estrone; Female; Humans; Menopause; Middle Aged; Pregnadienes | 1986 |
Estrogen production and metabolism in normal postmenopausal women and postmenopausal women with breast or endometrial cancer.
Topics: Aged; Body Weight; Breast Neoplasms; Endometrial Hyperplasia; Estradiol; Estrone; Female; Humans; Me | 1986 |
Plasma estrogens in postmenopausal women.
Topics: Adult; Age Factors; Aged; Body Weight; Castration; Diabetes Mellitus; Endometrial Hyperplasia; Endom | 1973 |
[Results of treatment of juvenile hemorrhagic metropathy with the authors method of hormone therapy, consisting of a combination of estrogen and progesterone].
Topics: Curettage; Drug Synergism; Endometrial Hyperplasia; Estrone; Female; Humans; Menorrhagia; Metrorrhag | 1973 |